Acne Treatments Global Market Report 2025

The acne treatments market size has grown strongly in recent years. It will grow from $8.29 billion in 2024 to $8.81 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth during the historic period can be attributed to the expansion of e-commerce and online pharmacies, rising demand for skincare products, increased adoption of combination therapy for acne treatment, growing disposable income, and a rising population of teenagers and young adults.

The acne treatments market size is expected to see strong growth in the next few years. It will grow to $11.15 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The projected growth in the forecast period can be attributed to a growing preference for organic and natural skincare products, a rising incidence of acne vulgaris, increasingly sedentary lifestyles, growing demand for hormonal therapies, and increased interest in herbal, organic, and DIY skincare solutions. Key trends expected during this period include advancements in dermatological research and technology, innovations in artificial intelligence (AI) and machine learning, the emergence of personalized acne treatments, technological progress in AI-powered acne diagnosis tools, and breakthroughs in drug delivery systems.

The rising prevalence of skin disorders is expected to drive the growth of the acne treatments market in the coming years. A skin disorder is any medical condition that affects the skin’s appearance, texture, or function. Factors such as increasing pollution, elevated stress levels, and hormonal imbalances are contributing to the growing incidence of these conditions, prompting individuals to seek targeted treatments that provide visible results, have minimal side effects, and are easy to incorporate into daily routines. Acne treatments play a significant role in managing skin disorders by reducing inflammation, preventing breakouts, and promoting the healing of damaged skin. For example, in July 2024, Cancer Research UK, a UK-based charity, reported that the average annual number of new melanoma skin cancer cases in the UK for 2023-2025 is around 20,800, with projections indicating a rise to 26,500 by 2038-2040. As a result, the increasing prevalence of skin disorders is contributing to the growth of the acne treatments market.

Leading companies in the acne treatments market are emphasizing a holistic and multi-targeted approach to acne care, such as developing multi-functional exfoliating and brightening formulations. These products are designed to not only treat acne but also enhance skin texture and reduce discoloration. A multi-functional exfoliating and brightening formulation typically includes ingredients that gently remove dead skin cells while diminishing dark spots and improving overall skin tone. For example, in November 2024, Proactiv Company, a U.S.-based skincare brand, introduced four new dermatologist-developed products addressing acne along with related issues like uneven texture, hyperpigmentation, and body blemishes. The new lineup features a salicylic acid cleanser, a brightening resurfacing mask, a blemish control body cream, and a travel-sized mini kit - providing a comprehensive acne treatment routine aimed at achieving clearer and healthier skin.

In December 2022, Beiersdorf AG, a Germany-based skincare company, acquired S-Biomedic for an undisclosed sum. This acquisition is intended to enhance Beiersdorf’s leadership in skincare innovation by incorporating S-Biomedic’s cutting-edge research and technologies in skin microbiome science. The integration supports the development of next-generation skincare products that align with the skin’s natural processes to address unmet consumer needs, including the treatment of acne. S-Biomedic, based in Belgium, is a biotechnology company specializing in skin microbiome research and the development of solutions for skin conditions such as acne.

Major players in the acne treatments market are CVS Health Corporation, McKesson Corporation, Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Sanofi S.A., L'Oréal S.A., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Henry Schein Inc., Shiseido Company Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy's Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Almirall S.A., Cipher Pharmaceuticals, and Diomed Developments Limited.

North America was the largest region in the acne treatments market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in acne treatments report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the acne treatments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Acne treatments encompass a broad spectrum of medical, cosmetic, and skincare solutions aimed at preventing, reducing, or eliminating acne by addressing underlying causes such as excess oil production, clogged pores, inflammation, and bacterial growth. These treatments are designed to control breakouts, enhance skin texture, minimize scarring, and restore overall skin clarity.

Key acne treatment products include retinoids, antibiotics, isotretinoin, and others. Retinoids, derived from vitamin A, are used in skincare and medicine to regulate cell turnover and treat conditions like acne and psoriasis. Acne treatments are classified by treatment type into oral and topical methods, offering options for either systemic or localized care. They are also categorized by acne type, such as inflammatory acne, cystic acne, and post-surgical or wound acne, to address different severities and underlying factors. Treatment options include medications, therapeutic interventions, and laser therapy, and are distributed through hospitals, clinics, pharmacies, drug stores, e-commerce platforms, and ambulatory surgical centers.

The acne treatments market research report is one of a series of new reports that provides acne treatments market statistics, including the acne treatments industry global market size, regional shares, competitors with the acne treatments market share, detailed acne treatments market segments, market trends, and opportunities, and any further data you may need to thrive in the acne treatments industry. This acne treatments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The acne treatments market consists of revenues earned by entities by providing services such as chemical peels, photodynamic therapy (PDT), microneedling, medical facials, corticosteroid injections, and extraction services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acne treatments market also includes sales of differin gel, Neutrogena Oil-Free Acne Wash, Proactiv 3-Step System, benzoyl peroxide, and Aviclear laser. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.